Addenbrookes Hospital

Cambridge, England CB2 2QQ

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Childhood Langerhans Cell Histiocytosis, Community-acquired Pneumonia, Influenza, COVID-19, Mucopolysaccharidosis II, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer — Completed
• Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II) — Completed
• A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis — Completed
• Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis — Completed